Poland – Pharmaceutical products – dostawa produktu leczniczego: Giwinostat 8,86 mg/ml, zaw.doustna,140 ml,1but.+1strzyk doust.
awardedUniwersytecki Szpital Kliniczny w Poznaniu
Value
PLN 1.2m
Published
28 Oct 2026
Deadline
—
Type
award
33600000 · Medical equipment, pharmaceuticals & personal carePL415
Description
dostawa produktu leczniczego: Giwinostat 8,86 mg/ml, zaw.doustna,140 ml,1but.+1strzyk doust
Key facts
- Procedure
- neg-wo-call
- Contact
- dzp@usk.poznan.pl
- Regime
- publicSector
- Contract references
- 01/AT/2026/WR
- Category
- supplies
Awarded suppliers
- Urtica Sp. z o.o. · 932081801 · PL911, PL
Supplier location as published: Wrocław, PL911, 54-613, PL
Ground given for limiting competition
The buyer’s own stated reason for awarding without open competition, as published. Their assertion, not a finding.
urgency
Włącznie nowych pacjentów w ramach terapii RDTL, wniosek na roczne zapotrzebowanie oddany, ilość na okres do czasu rozstrzygnięcia dużego postępowania.
What a subscription adds to this notice
- The documents — every attachment, with its text extracted and searchable
- Qualification — the notice scored against your company profile
- Tracking and alerts — a pipeline for your bids, and the matching notices by email
- The API and MCP — the same record in your own tools and your AI assistant
Provenance
- Source
- ted-eu
- Notice id
- 745572-2026
- First seen
- 28 Oct 2026
- Last updated
- 28 Oct 2026
Licence EU reuse — Commission Decision 2011/833/EU ↗
Source: TED — Tenders Electronic Daily (ted.europa.eu), © European Union, reused under Commission Decision 2011/833/EU.
View at source ↗
GET /api/v1/tenders/2c203e85-bea9-4903-b1d7-3bceebdc8a3aThe source notice is authoritative — verify deadlines and documents there before bidding.